Observational Registry on the HARPOON Device
- Conditions
- Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse
- Interventions
- Device: HARPOON Beating Heart Mitral Valve Repair System (MVRS)
- Registration Number
- NCT04393779
- Lead Sponsor
- Edwards Lifesciences
- Brief Summary
To collect data on the HARPOON™ Mitral Valve Repair System for use in patients with severe degenerative mitral regurgitation due to posterior leaflet prolapse.
- Detailed Description
This is a single arm, prospective, multicenter, post-market, observational registry that will evaluate subjects for up to 5 years post treatment.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 26
- Subjects who are clinically suitable for treatment with the HARPOON™ System, as per the Instructions for Use (IFU), will be evaluated for inclusion in the registry.
- N/A
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description HARPOON™ MVRS HARPOON Beating Heart Mitral Valve Repair System (MVRS) Subjects who were treated with the HARPOON MVRS.
- Primary Outcome Measures
Name Time Method Freedom From Re-operation Due to Recurrent Severe Mitral Regurgitation Through 1-year Post-implant 1 year post-implant Subject's freedom from re-operation due to recurrent severe mitral regurgitation through 1-year post-implant
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Hospital Son Espases
🇪🇸Palma, Illes Balears, Spain
Universitätsmedizin Göttingen
🇩🇪Göttingen, Niedersachsen, Germany
Rhön Klinikum Kardiochirurgie
🇩🇪Bad Neustadt, Bayern, Germany
Universitätsklinik Ulm
🇩🇪Ulm, Baden-Württemberg, Germany
Klinikum Passau
🇩🇪Passau, Bayern, Germany
Helios Universitätsklinikum Wuppertal
🇩🇪Wuppertal, Nordrhein-Westfalen, Germany
Insel Gruppe AG, Universitätsklinik für Kardiologie, Schweizer Herz- und Gefässzentrum Bern
🇨🇭Bern, Switzerland